Abstract
Mycoplasma genitalium has emerged as the causative agent of sexually transmitted syndromes including urethritis in men, cervicitis and pelvic inflammatory disease in women; however, testing should be limited to specific clinical scenarios. Treatment challenges include widespread macrolide resistance and the emergence of multidrug-resistant strains. Treatment failure is not uncommon and resistance-guided therapy currently offers the highest probability of cure.
| Original language | English |
|---|---|
| Pages (from-to) | 41-43 |
| Number of pages | 3 |
| Journal | Medicine Today |
| Volume | 21 |
| Issue number | 3 |
| Publication status | Published - Mar 2020 |